Innate immune recognition and suppression of tumors

被引:47
作者
Hayakawa, Yoshihiro [1 ]
Smyth, Mark J. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Trescowthick Labs, Canc Immunol Program, Melbourne, Vic 3002, Australia
来源
ADVANCES IN CANCER RESEARCH, VOL 95 | 2006年 / 95卷
关键词
D O I
10.1016/S0065-230X(06)95008-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
In this chapter, we first summarized the strong evidence that now supports the existence of an effective cancer immune surveillance process that prevents cancer development in both mice and humans. We then focused the remainder of the chapter on methods of tumor recognition that contribute to natural host immune suppression of tumors. In particular, NKG2D is a type If transmembrane-anchored glycoprotein expressed as a disulfide-linked homodimer on the surface of all mouse and human natural killer cells (NK cells). Stimulation of NK cell through NKG2D triggers cell-mediated cytotoxicity and in some cases induces production of cytokines. NKG2D binds to family of ligands with structural homology to major histocompatibility complex (MHC) class I, however, NKG2D ligands often display upregulated surface expression on stressed cells and are frequently overexpressed by tumors unlike conventional MHC class I molecules. Evidence clearly implicate that NKG2D recognition plays an important role in tumor immune surveillance. (c) 2006 Elsevier Inc.
引用
收藏
页码:293 / 322
页数:30
相关论文
共 172 条
[1]
AFFABRIS E, 1987, HAEMATOLOGICA, V72, P76
[2]
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[3]
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[4]
Interferon-alpha in tumor immunity and immunotherapy [J].
Belardelli, F ;
Ferrantini, M ;
Proietti, E ;
Kirkwood, JM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) :119-134
[5]
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway [J].
Billadeau, DD ;
Upshaw, JL ;
Schoon, RA ;
Dick, CJ ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2003, 4 (06) :557-564
[6]
Natural killer cells in antiviral defense: Function and regulation by innate cytokines [J].
Biron, CA ;
Nguyen, KB ;
Pien, GC ;
Cousens, LP ;
Salazar-Mather, TP .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :189-220
[7]
Human tumor antigens recognized by T lymphocytes [J].
Boon, T ;
vanderBruggen, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :725-729
[8]
Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects [J].
Borg, C ;
Terme, M ;
Taïeb, J ;
Ménard, C ;
Flament, C ;
Robert, C ;
Maruyama, K ;
Wakasugi, H ;
Angevin, E ;
Thielemans, K ;
Le Cesne, A ;
Chung-Scott, V ;
Lazar, V ;
Tchou, I ;
Crépineau, F ;
Lemoine, F ;
Bernard, J ;
Fletcher, JA ;
Turhan, A ;
Blay, JY ;
Spatz, A ;
Emile, JF ;
Heinrich, MC ;
Mécheri, S ;
Tursz, T ;
Zitvogel, L .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03) :379-388
[9]
IL-21 induces the functional maturation of murine NK cells [J].
Brady, J ;
Hayakawa, Y ;
Smyth, MJ ;
Nutt, SL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2048-2058
[10]
BURNET M, 1957, BRIT MED J, V5023, P841